Cite

HARVARD Citation

    Wu, L. et al. (2017). Open-label phase I clinical trial of Ad5-EBOV in Africans in China. Human vaccines & immunotherapeutics. 13 (9), pp. 2078-2085. [Online]. 
  
Back to record